PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020279
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020279
The global C-Arms market was valued at USD 2.12 billion in 2025 and is projected to grow to USD 2.22 billion in 2026, reaching an estimated USD 3.19 billion by 2034, reflecting a compound annual growth rate (CAGR) of 4.65% during the forecast period. North America dominated the market in 2025, accounting for 53.64% of the global revenue, driven by the introduction of technologically advanced hybrid C-Arms and the strong presence of key market players focusing on product innovation.
C-Arms are X-ray-based devices connecting an X-ray source with a detector, providing non-invasive diagnostic imaging primarily used in cardiac and orthopedic procedures. Installed on the patient's table, these systems deliver real-time imaging, allowing surgeons to monitor procedures effectively. The increasing preference for minimally invasive procedures-due to reduced operation time, faster recovery, and cost-effective outpatient care-has significantly boosted market demand. Chronic diseases like diabetes, cancer, and cardiovascular conditions are contributing to the rising need for advanced imaging systems.
For example, data from the American Society of Anesthesiologists (ASA) in May 2021 indicated that approximately 70% of surgical procedures in the U.S. were performed in outpatient settings, highlighting the growing trend of ambulatory surgeries. Similarly, the Centers for Disease Control and Prevention (CDC) reported in July 2022 that 805,000 people in the U.S. experience a heart attack annually, with 605,000 being first-time cases. These statistics underscore the demand for advanced imaging solutions such as C-Arms to improve procedural outcomes.
Impact of COVID-19
The COVID-19 pandemic temporarily impeded market growth due to fewer patient visits and reduced surgical procedures. Supply chain disruptions and the reallocation of healthcare resources caused revenue declines for major players. However, by Q3-Q4 of 2020, patient visits began rising as travel restrictions eased, and by 2021, the normalization of hospital visits-alongside higher vaccination rates and COVID-19 protocols-led to increased demand for medical imaging devices.
Key Market Trends
Artificial Intelligence (AI) Integration: AI adoption in radiology has been a major growth driver. For instance, in December 2021, Boston University developed an AI algorithm capable of rapidly detecting fractures in X-rays, improving operational efficiency. Similarly, Omega Medical Imaging, LLC launched Soteria.AI in April 2022, reducing radiation dosage by 84% while enhancing image quality. AI-powered 3D mapping is also gaining traction, with companies like Koninklijke Philips N.V. and Siemens Healthcare GmbH developing systems to improve surgical precision and efficiency.
Technological Advancements: The development of mobile and fixed C-Arms with flat panel detectors allows for improved imaging quality while reducing radiation exposure. For instance, Ziehm Imaging introduced the IGZO1 flat-panel detector in July 2022, offering high-resolution intraoperative imaging with minimal radiation.
Market Segmentation
By Type: The mobile segment dominated with 61.27% market share in 2026, driven by demand for versatile, portable imaging systems. Fixed C-Arms are also gaining traction due to approvals for cardiovascular procedures in outpatient and office-based labs.
By Application: Cardiology leads the market, capturing 43.7% of market share in 2026, due to the prevalence of coronary heart disease. Orthopedics & trauma are expected to record the highest CAGR, supported by regulatory approvals for advanced surgical imaging devices. Oncology and other specialties are witnessing steady growth through hospital partnerships and technological collaborations.
By Detector: Flat panel detectors hold 80.46% share in 2026, favored for their ability to simplify medical procedures and improve imaging precision. Image intensifiers are growing at a slower pace but remain essential in specific surgical workflows.
By End-User: Hospitals dominate the market with 52.76% share in 2026, benefiting from collaborations with manufacturers to adopt advanced imaging systems, enhancing the quality of care. Diagnostic centers and specialty clinics are gradually increasing adoption due to rising outpatient procedures.
Competitive Landscape
Major players dominating the market include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthcare GmbH (Germany), Canon Medical Systems Corporation (Japan), Ziehm Imaging GmbH (Germany), FUJIFILM (Japan), and Genoray Co., Ltd. (South Korea). These companies focus on new product launches, AI integration, and strategic collaborations. Notable recent developments include:
Conclusion
The global C-Arms market is poised for steady growth from USD 2.22 billion in 2026 to USD 3.19 billion by 2034, driven by increasing preference for minimally invasive procedures, chronic disease prevalence, AI integration, and continuous technological innovations. North America remains the key market, while emerging economies in Asia Pacific are witnessing significant adoption due to expanding healthcare infrastructure and investments in advanced imaging technologies.
Segmentation By Type
By Application
By Detector
By End-user
By Region